X-134475285-A-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PP3_StrongPP5_Moderate
The ENST00000298556.8(HPRT1):c.239A>T(p.Asp80Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D80E) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000298556.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPRT1 | NM_000194.3 | c.239A>T | p.Asp80Val | missense_variant | 3/9 | ENST00000298556.8 | NP_000185.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPRT1 | ENST00000298556.8 | c.239A>T | p.Asp80Val | missense_variant | 3/9 | 1 | NM_000194.3 | ENSP00000298556 | P1 | |
HPRT1 | ENST00000462974.5 | n.397A>T | non_coding_transcript_exon_variant | 3/8 | 3 | |||||
HPRT1 | ENST00000475720.1 | n.197A>T | non_coding_transcript_exon_variant | 2/8 | 3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 27
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Partial hypoxanthine-guanine phosphoribosyltransferase deficiency Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 1989 | - - |
Lesch-Nyhan syndrome;C0268117:Partial hypoxanthine-guanine phosphoribosyltransferase deficiency Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2021 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this variant affects HPRT1 protein function (PMID: 25481104). This variant has been observed in individual(s) with clinical features of HPRT deficiency (PMID: 20176575, 2738157, Invitae). This variant is also known as HPRT Arlington in the literature. ClinVar contains an entry for this variant (Variation ID: 10030). This variant is not present in population databases (ExAC no frequency). This sequence change replaces aspartic acid with valine at codon 80 of the HPRT1 protein (p.Asp80Val). The aspartic acid residue is highly conserved and there is a large physicochemical difference between aspartic acid and valine. - |
HPRT ARLINGTON Other:1
other, no assertion criteria provided | literature only | OMIM | Sep 10, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at